# Purification of Monoclonal Antibodies Using Chromatographic Methods: Increasing Purity and Recovery

**Authors:** Elnazalsadat Jafarzadeh Chehraghi, Parvin Akbarzadehlaleh, Karim Shamsasenjan

PMC · DOI: 10.34172/apb.43967 · Advanced Pharmaceutical Bulletin · 2025-01-05

## TL;DR

This paper reviews chromatographic methods for purifying monoclonal antibodies to improve purity, recovery, and efficiency in biopharmaceutical production.

## Contribution

The paper highlights recent advancements in chromatographic techniques, such as multi-modal ligands and continuous processing, for monoclonal antibody purification.

## Key findings

- Chromatographic methods like affinity and ion exchange chromatography are widely used for monoclonal antibody purification.
- Recent innovations include multi-modal ligands and membrane adsorbers to improve purification efficiency and reduce costs.
- Continuous processing is emerging as a promising trend in mAb purification.

## Abstract

Monoclonal antibodies (mAbs) have gained increasing significance in biopharmaceutical research and production because of their precise targeting and therapeutic potential. The purification of mAbs is a crucial stage in production, ensuring the elimination of impurities for a top-quality, safe, and efficient final product. Chromatographic methods including affinity chromatography, ion exchange chromatography, and hydrophobic interaction chromatography (HIC) are commonly utilized to selectively capture and purify mAbs from complex mixtures by exploiting their unique properties, such as antigen-binding specificity or their surface charge and hydrophobicity. This review provides an overview of the current chromatographic techniques for mAbs purification, and to this aim delves into recent advancements and emerging trends in mAb purification, including the application of multi-modal ligands, membrane adsorbers, and continuous processing. These innovations aim to enhance efficiency, selectivity, and reliability while reducing processing time and costs, ultimately contributing to the development of safe and effective mAb-based therapies. Emphasis is placed on the necessity of choosing suitable methods based on the unique properties of the mAb and the desired quality attributes of the end product.

## Full-text entities

- **Genes:** IL-18 [NCBI Gene 100034216], KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, Igha (immunoglobulin heavy constant alpha) [NCBI Gene 238447] {aka IgA, Igh-2}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}
- **Diseases:** cancer (MESH:D009369), ADCs (MESH:D009759), MCC (MESH:C536342), MS (MESH:D009103), B-cell malignancies (MESH:D016393), breast cancer (MESH:D001943)
- **Chemicals:** polyacrylamide (MESH:C016679), acetonitrile (MESH:C032159), trastuzumab (MESH:D000068878), EDTA (MESH:D004492), PEG (MESH:D011092), carboxylic acids (MESH:D002264), glycan (MESH:D011134), nickel (MESH:D009532), thioether (MESH:D013440), tocilizumab (MESH:C502936), formic acid (MESH:C030544), salt (MESH:D012492), NTA (MESH:D009571), Phosphate (MESH:D010710), sodium chloride (MESH:D012965), emicizumab (MESH:C000608208), Metal (MESH:D008670), glycine (MESH:D005998), SP (MESH:C000604007), Bevacizumab (MESH:D000068258), SDS (MESH:D012967), Atezolizumab (MESH:C000594389), pertuzumab (MESH:C485206), imidazole (MESH:C029899), TFA (MESH:D014269), Hydroxyapatite (MESH:D017886), urea (MESH:D014508), rituximab (MESH:D000069283), sodium phosphate (MESH:C018279), Polyallylamine (MESH:C063994), ASAP (MESH:C070385), dextran (MESH:D003911), CHT (-), guanidine HCl (MESH:D019791), calcium (MESH:D002118), A (MESH:D001151), hydrogen (MESH:D006859), MEP (MESH:C064603), (NH4) 2SO4 (MESH:D000645), Sepharose (MESH:D012685), ammonium acetate (MESH:C018824), cysteine (MESH:D003545), furaltadone (MESH:C007795)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Escherichia coli (E. coli, species) [taxon 562], Homo sapiens (human, species) [taxon 9606], Oryza sativa (Asian cultivated rice, species) [taxon 4530], Equus caballus (domestic horse, species) [taxon 9796], Nicotiana benthamiana (species) [taxon 4100]
- **Cell lines:** CHO — Cricetulus griseus (Chinese hamster), Spontaneously immortalized cell line (CVCL_0213)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12235372/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12235372/full.md

## References

143 references — full list in the complete paper: https://tomesphere.com/paper/PMC12235372/full.md

---
Source: https://tomesphere.com/paper/PMC12235372